Results 71 to 80 of about 162,168 (205)

Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection [PDF]

open access: yes, 2008
Autoimmune liver diseases, such as autoimmune hepatitis (AIH) and primary biliary cirrhosis, often have severe consequences for the patient. Because of a lack of appropriate animal models, not much is known about their potential viral etiology. Infection
Hintereder, Gudrun   +23 more
core   +1 more source

Hepatitis E Virus in Livestock—Update on Its Epidemiology and Risk of Infection to Humans

open access: yes, 2023
Hepatitis E virus (HEV) is a public health problem worldwide and an important food pathogen known for its zoonotic potential. Increasing numbers of infection cases with human HEV are caused by the zoonotic transmission of genotypes 3 and 4, mainly by ...
Jarosław Wojciechowski   +3 more
core   +1 more source

Serologic study of pig-associated viral zoonoses in Laos

open access: yes, 2012
We conducted a serologic survey of four high-priority pig-associated viral zoonoses, Japanese encephalitis virus (JEV), hepatitis E virus (HEV), Nipah virus (NiV), and swine influenza virus (SIV), in Laos. We collected blood from pigs at slaughter during
Jarman, R.G.   +15 more
core   +1 more source

Are Viral Vectors Any Good for RNAi Antiviral Therapy?

open access: yesViruses, 2020
RNA interference (RNAi) represents a novel approach for alternative antiviral therapy. However, issues related to RNA delivery and stability have presented serious obstacles for obtaining good therapeutic efficacy.
Kenneth Lundstrom
doaj   +1 more source

Liver chimeric mice with tupaia hepatocyte transplantation as an animal model for hepatitis B virus infection and antiviral therapy

open access: yesBiosafety and Health, 2019
The human liver chimeric mouse is a milestone animal model for hepatitis B virus (HBV) infection. Such mice with primary human hepatocyte (PHH) transplantation are adequate to support chronic HBV infection for several weeks and to evaluate antiviral ...
Lunzhi Yuan   +8 more
doaj   +1 more source

Pharmacothera-peutic activity Lomatogonium Carinthiacum extract at experimental hepatitis

open access: yesActa Biomedica Scientifica, 2013
Pharmacotherapeutic efficiency of the dry extract from Lomatogonium carinthiacum in toxic hepatitis was studied. Experimental hepatitis was caused by the introduction of tetracycline hydrochloride to Wistar white rats in the dose of 1,0 g/kg of the ...
A. V. Fedorov   +5 more
doaj  

PHARMACOTHERAPY OF EXPERIMENTAL HEPATITIS BY LOMATOGONIUM CARINTHIACUM EXTRACT

open access: yesActa Biomedica Scientifica, 2014
Pharmacotherapeutic efficiency of the dry extract from Lomatogonium carinthiacum in toxic hepatitis was studied. Experimental hepatitis was caused by the introduction of tetracycline hydrochloride to Wistar white rats in the dose of 1.0 g/kg of the ...
A. V. Fedorov   +5 more
doaj  

Stimulation requirement and pathogenetic significance of T cells during chronic viral hepatitis.

open access: yes, 2007
Hepatitis B virus (HBV) and Hepatitis C virus (HCV) are important causes of liver inflammation and fibrosis. More than 500 million people are persistently infected worldwide and consequently are at increased risk of developing chronic liver disease ...
Kennedy, P.
core  

Hepatitis E Viruses : Emerging and Transboundary Animal Viruses

open access: yes, 2020
Hepatitis E virus (HEV), member of genus Orthohepevirus in the family Hepeviridae, is the leading cause of hepatitis E. More than 20 million cases of hepatitis E virus (HEV) infection have been reported globally, out of which 3.3 million suffered from
Kamar, Nassim   +7 more
core   +1 more source

Zoonotic hepatitis E: animal reservoirs and emerging risks

open access: yes, 2010
Hepatitis E virus (HEV) is responsible for enterically-transmitted acute hepatitis in humans with two distinct epidemiological patterns. In endemic regions, large waterborne epidemics with thousands of people affected have been observed, and, in contrast,
Meng, Xiang-Jin   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy